Does BCBS Michigan cover Zepbound? For weight loss, usually not in 2026. Blue Cross Blue Shield of Michigan and Blue Care Network excluded weight-loss GLP-1s for fully insured large groups starting in 2025, and individual and small group plans exclude them too. Some self-funded employer plans still cover the Zepbound auto-injector with prior authorization.
Below we cover which BCBS Michigan plans still pay, the two sets of prior authorization rules, what Michigan Medicaid and Medicare members can do, and what Zepbound costs if you pay cash.
Quick answer by BCBS Michigan plan type
| Your plan | Zepbound for weight loss | Zepbound for sleep apnea | Your best next step |
|---|---|---|---|
| Fully insured large group (employer buys a BCBSM or BCN plan) | Not covered since 2025 | Not listed as covered in the 2026 drug list for these groups | Cash pay, or ask HR about plan options |
| Self-funded employer plan (ASO) | Depends on your employer; may be covered with prior authorization | Depends on your employer | Check your benefits, then request prior authorization |
| Individual, family or small group (Custom Select drug list) | Not covered | Excluded in the state-reviewed case below | Cash pay |
| Michigan Medicaid (including Blue Cross Complete of Michigan) | Only BMI 40+ after other options fail | Ask your health plan | Talk to your doctor about the state criteria |
| Medicare (a Blue Cross or BCN Medicare plan with drug coverage) | Through Medicare's GLP-1 Bridge if eligible | Not through the Bridge | Ask your doctor about the Bridge |
Not sure which of these routes is yours? The RX Index's free quiz sorts it out in about two minutes.
Find your GLP-1 path in 2 minutes
What changed at BCBS Michigan in 2025
In September 2024, Blue Cross Blue Shield of Michigan told providers that, starting January 1, 2025 (or at the group's 2025 renewal), BCBSM and Blue Care Network would no longer cover GLP-1 drugs used for weight loss, including Saxenda, Wegovy and Zepbound, for commercial fully insured large group members with prescription coverage. The same notice said some self-funded groups had also chosen to remove the benefit (BCBSM provider alert, September 27, 2024).
That policy is still in place. BCBSM's 2026 Clinical Drug List says: "We don't cover glucagon-like peptide-agonist drugs used for weight loss, including Saxenda®, Wegovy®, and Zepbound® for commercial members of fully insured large groups and some self-funded groups" (BCBSM 2026 Clinical Drug List).
The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.
Fully insured or self-funded: how to tell
This one distinction decides most BCBS Michigan Zepbound questions.
- Fully insured: your employer buys a ready-made plan from BCBSM or BCN, and Blue Cross carries the risk. Since 2025, these large group plans exclude weight-loss GLP-1s.
- Self-funded (also called ASO): your employer pays claims itself and hires Blue Cross to run the plan. The employer decides whether weight-loss drugs are covered. Some still cover them and some dropped them.
Your HR or benefits team can tell you which type you have. You can also check your benefits booklet or call the member number on your card and ask: "Is my plan fully insured or self-funded, and does my pharmacy benefit cover drugs for weight loss?"
Your plan type isn't the only thing that matters. BCBSM's prior authorization guide says Zepbound "coverage criteria is determined by group benefit," so two self-funded employers can have different rules (BCBSM prior authorization and step therapy guidelines, revised November 1, 2026).
Which Zepbound pen BCBS Michigan lists
The 2026 Clinical Drug List treats the two Zepbound pens differently:
| Drug | 2026 Clinical Drug List status |
|---|---|
| Zepbound single-dose auto-injector pen | Preferred brand, prior authorization and quantity limits |
| Zepbound KwikPen | Not covered |
| Wegovy pen | Preferred brand, prior authorization and quantity limits |
| Wegovy pill | Not covered |
| Foundayo pill | Preferred brand, prior authorization and quantity limits |
These statuses apply only where the group's benefit includes weight-loss drugs. "Preferred brand" doesn't mean a fully insured large group member is covered for weight loss. It means that if your plan has the benefit, this is the product it pays for, after approval.
So if your self-funded plan covers Zepbound, the prescription needs to be for the single-dose auto-injector, not the KwikPen.
BCBS Michigan Zepbound prior authorization rules
When a BCBS Michigan plan does include the benefit, Zepbound needs prior authorization. BCBSM's November 2026 guide lists two sets of criteria. Which one applies depends on your employer's benefit design, so ask your plan which applies to you.
Criteria set 1: BMI and attestation
| Requirement | What BCBSM asks for |
|---|---|
| Age | 18 or older |
| Weight | BMI of 30 or higher, or 27 or higher with a weight-related condition |
| Sleep apnea route | Moderate to severe obstructive sleep apnea with a BMI of 30 or higher |
| Lifestyle | Your doctor attests that you're following a lifestyle program |
| Other drugs | Not combined with other weight-loss drugs or GLP-1s |
| First approval | 1 year |
| Renewal | Attestation that you've kept off at least 5% of your starting weight, plus your current weight |
Criteria set 2: BMI 35 and a documented program
This stricter set appears in the same guide and asks for much more paperwork:
| Requirement | What BCBSM asks for |
|---|---|
| Age | 18 or older |
| Weight | BMI of 35 or higher, with a current weight from the last 30 days |
| Lifestyle program | At least 6 months of documented lifestyle changes, such as food diaries or exercise logs |
| Teladoc | Current, active participation in the Teladoc Health Weight Management Program (meeting with a coach and having a plan of action) |
| Prescriber | A primary care doctor or an established in-person provider |
| Diabetes | Not for type 2 diabetes (Mounjaro is the tirzepatide product for that) |
| First approval | 6 months |
| Renewal | At least 5% weight loss, ongoing lifestyle records and Teladoc participation, filling the drug on schedule at least 80% of the time |
The guide also marks Zepbound as not covered on the Blue Cross Custom Select and BCN Custom Select drug lists. BCBSM's individual, family and small group plans (50 or fewer employees) use those Custom Select lists (BCBSM 2026 drug lists).
If you're applying, your doctor's office will usually need your BMI history, a recent weight, any related diagnoses and records of your lifestyle program. Our GLP-1 prior authorization documents checklist lists what to gather.
Who reviews BCBS Michigan pharmacy claims
OptumRx is the pharmacy benefit manager for BCBSM and BCN commercial members. Prescribers can check coverage and out-of-pocket cost before writing the prescription with BCBSM's real-time benefit tool, PreCheck MyScript, through Availity (BCBSM real-time prescription benefit flyer). The same flyer repeats that these drugs have been excluded for fully insured group members since January 1, 2025, may be covered for certain self-funded groups, and that criteria vary by employer.
For more on how OptumRx handles Zepbound, see does OptumRx cover Zepbound and OptumRx Zepbound prior authorization.
If your self-funded plan may cover Zepbound, Ro can check your benefits and handle the prior authorization for the auto-injector pen. Ro's insurance help covers the Wegovy pen, the Zepbound auto-injector pen and Ozempic, and Ro says prior authorization usually takes about 1 to 2 weeks. Insurance doesn't pay Ro's membership fee (Ro insurance page, ro.co/weight-loss/insurance, checked November 10, 2026).
Check whether your BCBS Michigan plan covers Zepbound (sponsored affiliate link, opens in a new tab)
If your approved plan covers Zepbound
Lilly's savings card can lower the cost. Lilly says people with commercial insurance that covers Zepbound may pay as little as $25 for a 1-month or 3-month supply of Zepbound single-dose pens. Government plans are excluded (Lilly Zepbound cost information). Details are in our Zepbound savings card guide and Zepbound cost with insurance.
What the state said about a BCBS Michigan Zepbound denial
Michigan's Department of Insurance and Financial Services (DIFS) reviewed a BCBSM Zepbound denial in February 2026. The member had a Simply Blue HSA small group plan with the 2026 Custom Select Drug List. BCBSM denied Zepbound because the plan's pharmacy benefit "does not cover ANY medications that are used to treat obesity," and its letter said Wegovy and Zepbound were excluded for every FDA-approved use, including sleep apnea.
The plan certificate excludes "lifestyle drugs, such as ... drugs used for weight loss." The DIFS Director upheld the denial because it matched the plan terms, even though the member had related health conditions (Michigan DIFS order, File No. 243951-001, February 27, 2026).
An appeal can fix a wrong medical judgment, but it rarely beats a written exclusion. Before you appeal, read our guide on plan exclusion vs prior authorization. If your denial was for medical necessity rather than an exclusion, how to appeal a Zepbound denial and external review for a GLP-1 denial walk through the steps.
Does BCBS Michigan cover Zepbound for sleep apnea?
Zepbound is FDA-approved for two uses: chronic weight management in adults with obesity, or overweight with a weight-related condition, and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound prescribing information, revised August 2026).
BCBSM's prior authorization guide includes a sleep apnea route with a BMI of 30 or higher, but only where your group's benefit allows Zepbound. The 2026 Clinical Drug List exclusion names Zepbound without carving out sleep apnea, and in the DIFS case above the denial letter said Zepbound was excluded for sleep apnea too. If you have a sleep apnea diagnosis, ask BCBSM directly whether your plan covers Zepbound for it, and bring your sleep study results. More in does insurance cover Zepbound for sleep apnea.
What Zepbound costs if BCBS Michigan won't cover it
For most BCBS Michigan members, Zepbound for weight loss means paying cash.
On Ro's pricing page, the Zepbound KwikPen is cash-pay only: $299 a month at 2.5 mg, $399 at 5 mg, and $449 at 7.5 mg through 15 mg with the manufacturer offer. To keep the $449 price, Ro says you must complete each refill check-in within 45 days of your last delivery, or the price rises to $499 at 7.5 mg and $699 at 10 to 15 mg. Ro says its cash prices match LillyDirect, NovoCare and TrumpRx. The Ro membership is extra: $39 the first month (refunded if you're not eligible), then $74 to $149 a month depending on plan length. The $74 rate is on a 12-month plan paid upfront (Ro pricing, ro.co/weight-loss/pricing, checked November 10, 2026).
Your first-year cash cost for Zepbound through Ro
This is the whole receipt, not only the sticker price. It assumes one dose step per month up to 7.5 mg, which is a common pattern but not a dosing plan. Your prescriber decides your dose.
| Month | Zepbound KwikPen dose (example) | Medication | Ro membership (monthly plan) | Total that month |
|---|---|---|---|---|
| 1 | 2.5 mg | $299 | $39 | $338 |
| 2 | 5 mg | $399 | $149 | $548 |
| 3–12 | 7.5 mg or higher | $449 × 10 = $4,490 | $149 × 10 = $1,490 | $598 a month ($5,980) |
| Year one | $5,188 | $1,678 | $6,866 |
With Ro's 12-month plan paid upfront, membership is as low as $74 a month ($888 due at once), which lowers the yearly membership cost. Math by The RX Index from Ro's listed prices on November 10, 2026. Prices can change.
Lilly's Zepbound savings card won't help if your plan excludes Zepbound. It requires commercial insurance that covers Zepbound.
Other cash routes to compare: the cheapest Zepbound without insurance and how to get the Zepbound KwikPen online.
See Ro's Zepbound KwikPen cash prices (sponsored affiliate link, opens in a new tab)
If Zepbound's cash price is too high
You have other FDA-approved options with lower cash prices on Ro. Ro lists the Wegovy pen starting at $199 a month and, for new patients, the first dose of the Wegovy pill or Foundayo pill at $149 a month, plus membership (Ro pricing). These are different medicines with different dosing and results, so the choice belongs with your prescriber.
Compare Ro's cash GLP-1 options (sponsored affiliate link, opens in a new tab)
BCBS Michigan Medicaid: the BMI 40 rule
Blue Cross's Michigan Medicaid plan, Blue Cross Complete of Michigan, follows the state's pharmacy rules. Since January 1, 2026, Michigan Medicaid covers GLP-1s for weight loss only in narrow cases. The state says you must be classified as morbidly obese, and the drug can be used "only as a measure to avert the need for higher-cost bariatric surgery" (Michigan Medicaid letter L 25-73, December 8, 2025).
Michigan's preferred drug list criteria spell that out for Zepbound:
| Requirement | What Michigan Medicaid asks for |
|---|---|
| Age | 18 or older |
| BMI | Morbid obesity, for example a starting BMI of 40 or higher |
| Other drugs first | Tried and failed, or can't take, all five types of preferred weight-loss drugs |
| Purpose | Used to avoid higher-cost bariatric surgery |
| Approval length | 6 months at first, then 6-month renewals |
| Renewal | At least 5% weight loss from your starting weight |
Source: Michigan single PDL criteria for anti-obesity GLP-1s. For other states, see GLP-1 Medicaid coverage by state and does Medicaid cover Zepbound.
Ro doesn't take Medicaid, so Medicaid members should work through their own doctor and health plan.
BCBS Michigan Medicare plans and the GLP-1 Bridge
Medicare Part D plans still can't cover drugs for weight loss on their own. Since July 1, 2026, Medicare's GLP-1 Bridge has covered certain weight-loss GLP-1s for eligible people with Part D, including Medicare Advantage plans with drug coverage. The Bridge covers the Zepbound KwikPen, not the single-dose pens or vials, along with Wegovy and Foundayo, for $50 for a one-month supply (Medicare.gov: weight-loss drugs).
You may qualify if you're 18 or older, in a lifestyle program, and have:
- A BMI of 35 or higher, or
- A BMI of 30 or higher with heart failure with preserved ejection fraction, uncontrolled high blood pressure, or chronic kidney disease stage 3a or higher, or
- A BMI of 27 or higher with prediabetes, a past heart attack or stroke, or symptomatic peripheral artery disease
People with type 2 diabetes, moderate to severe sleep apnea, or fatty liver disease aren't eligible for the Bridge because their plan may already cover a GLP-1 for those uses. Bridge approvals run through December 31, 2027. The $50 copay doesn't count toward your Part D deductible or out-of-pocket limit. Full details are in our Medicare GLP-1 Bridge guide.
Your options, side by side
| Route | Who it fits | Monthly cost you'll see | What to do next |
|---|---|---|---|
| Self-funded BCBS Michigan plan with the benefit | Employers that kept weight-loss coverage | Your copay, possibly $25 with Lilly's card | Prior authorization for the auto-injector |
| Cash through Ro | Excluded plans, or anyone who wants to skip insurance | $299 to $449 for the KwikPen, plus membership | See Ro's cash prices |
| Michigan Medicaid | BMI 40+ after other drugs fail | Medicaid copay | Ask your doctor about the state criteria |
| Medicare GLP-1 Bridge | Eligible people with Part D or Medicare Advantage drug coverage | $50 | Ask your doctor |
| Ask your employer | Fully insured or excluded plans at renewal time | n/a | Use our employer request guide |
What we actually verified
- BCBSM's 2026 Clinical Drug List and its prior authorization and step therapy guidelines (revised November 1, 2026), read in full for GLP-1 entries on November 10, 2026.
- BCBSM's September 2024 provider alert and its real-time benefit check flyer.
- The Michigan DIFS external review order on a 2026 BCBSM Zepbound denial.
- Michigan Medicaid's letter L 25-73 and the state's anti-obesity GLP-1 criteria.
- Medicare.gov's GLP-1 Bridge page, Lilly's Zepbound cost page and the Zepbound label.
- Ro's pricing and insurance pages for cash prices, membership and which pens Ro's insurance team handles.
We didn't call BCBSM or Blue Care Network, and we can't see your employer's plan. Your benefits booklet and the member number on your card are the final word.
Frequently asked questions
Does BCBS Michigan cover Zepbound for weight loss in 2026?
Usually not. Fully insured large group, individual and small group plans exclude it. Some self-funded employer plans still cover the Zepbound auto-injector with prior authorization.
Does Blue Care Network cover Zepbound?
Blue Care Network made the same 2025 change as BCBSM. Fully insured BCN large group plans exclude weight-loss GLP-1s, and BCBSM's guide marks Zepbound as not covered on the BCN Custom Select list.
Does BCBS Michigan cover the Zepbound KwikPen?
No. The 2026 Clinical Drug List lists the KwikPen as not covered and the single-dose auto-injector as the preferred pen where a group covers Zepbound.
How do I know if my BCBS Michigan plan is self-funded?
Ask your HR team, check your benefits booklet, or call the member number on your card. Self-funded plans are often called ASO plans.
What does BCBS Michigan require for Zepbound prior authorization?
It depends on your group. One set asks for a BMI of 30, or 27 with a related condition. A stricter set asks for a BMI of 35, 6 months of documented lifestyle changes and Teladoc's weight program.
Can I appeal a BCBS Michigan Zepbound denial?
Yes, but if the plan excludes weight-loss drugs, an appeal rarely wins. Michigan's insurance regulator upheld a 2026 BCBSM exclusion denial.
How much is Zepbound without insurance in Michigan?
On Ro, the Zepbound KwikPen costs $299 to $449 a month depending on dose, plus Ro's membership ($39 the first month, then $74 to $149 a month).
Does Michigan Medicaid cover Zepbound?
Only in narrow cases since January 2026: a BMI of about 40 or higher, after other weight-loss drugs fail, to avoid bariatric surgery.
Sources
- BCBSM: 2026 Clinical Drug List; prior authorization and step therapy guidelines (revised November 1, 2026); provider alert, September 27, 2024; real-time prescription benefit check flyer; 2026 drug lists page (all checked November 10, 2026)
- Michigan DIFS order, File No. 243951-001 (February 27, 2026; checked November 10, 2026)
- Michigan Medicaid: Letter L 25-73; single PDL anti-obesity GLP-1 criteria (checked November 10, 2026)
- Medicare.gov: weight-loss drugs and the GLP-1 Bridge (checked November 10, 2026)
- Lilly: Zepbound cost information and Zepbound prescribing information (revised August 2026; checked November 10, 2026)
- Ro: pricing and insurance (checked November 10, 2026)
Related: does Blue Cross cover Zepbound, Blue Cross Zepbound prior authorization, does Priority Health cover Zepbound, insurance stopped covering Zepbound, does Ro take Blue Cross Blue Shield.
Do not use Zepbound if you or a family member has had medullary thyroid cancer (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2). Zepbound has a boxed warning about thyroid C-cell tumors. Tell your prescriber if you're pregnant or planning a pregnancy. Get care right away for severe stomach pain that won't go away (Zepbound prescribing information, revised August 2026).
Still not sure which GLP-1 path fits you? Take The RX Index's free Find My GLP-1 Path quiz — about 2 minutes, no signup.